Chronic Kidney Disease: Breaking Barriers with Cardiovascular and Renal Integration in Clinical Trials, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn about the historical exclusion of chronic kidney disease (CKD) from clinical trials and the considerations and reasons to increase the CKD population in clinical trials. Attendees will learn the value of integrated approaches to clinical trials including cardiorenal. The featured speakers will discuss cardiorenal case studies to exemplify how cross collaboration and integration lead to overall clinical trial success. The speakers will discuss an operational perspective on the value of therapeutically aligned clinical operations teams and operational lessons learned from cross collaboration.

TORONTO, June 7, 2023 /PRNewswire-PRWeb/ -- 21st century medicine and technology has seen exciting advancements at a pace and scale so remarkable that it exceeds the medical trajectory as compared to all of human history combined. This evolution, marked by preventative measures in healthcare, has improved the longevity and quality of life for patients, which also equates to a rising incidence and prevalence of chronic disease, especially chronic kidney disease (CKD).

Indeed, chronic kidney disease is now the 10th leading cause of mortality compared to the early 1990's when it was over the 35th leading cause, with projections over time placing it much higher on the ranking in the future. Historically, however, those with chronic kidney disease have represented a population traditionally excluded from clinical trials, especially those in cardiovascular disease despite the improved understanding of its implications related to comorbid diseases.

Despite the inherent complexities of chronic kidney disease, with its intricate bidirectional cardiovascular effect, along with being one of the strongest risk factors for cardiovascular death, there has never been a more important time to include those with chronic kidney disease in clinical trials, especially those related to cardiovascular disease. An understanding of integrated approaches toward expanding this population in clinical trials will ultimately benefit not only both patients and Sponsors alike, but also will have a positive global impact on disease burden while also continuing to evolve the thinking on chronically ill populations.

Join this webinar to learn about integrated approaches to include patients with chronic kidney disease in cardiovascular clinical trials, benefiting both patients and improving disease burden worldwide.

Join experts from Medpace, Dr. Ajay Srivastava, MD, FASN, Sr. Vice-President, Medical Department; Dr. Nicholas Alp, MD, PhD, FACC, Sr. Vice-President, Medical Department; and Heather Lohr, Sr. Director, Clinical Trial Management, for the live webinar on Thursday, June 22, 2023, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Chronic Kidney Disease: Breaking Barriers with Cardiovascular and Renal Integration in Clinical Trials.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]

SOURCE Xtalks